Merit Medical Systems, Inc. (MMSI) Shares Bought by Rhumbline Advisers

Rhumbline Advisers raised its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,080 shares of the medical instruments supplier’s stock after purchasing an additional 2,295 shares during the period. Rhumbline Advisers owned approximately 0.19% of Merit Medical Systems worth $4,027,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in MMSI. LS Investment Advisors LLC raised its position in Merit Medical Systems by 8.1% during the second quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock valued at $141,000 after purchasing an additional 277 shares in the last quarter. Aperio Group LLC raised its position in Merit Medical Systems by 3.9% during the second quarter. Aperio Group LLC now owns 10,467 shares of the medical instruments supplier’s stock valued at $399,000 after purchasing an additional 391 shares in the last quarter. Russell Investments Group Ltd. raised its position in Merit Medical Systems by 1,151.1% during the second quarter. Russell Investments Group Ltd. now owns 359,195 shares of the medical instruments supplier’s stock valued at $13,704,000 after purchasing an additional 330,484 shares in the last quarter. Strs Ohio raised its position in Merit Medical Systems by 1.7% during the second quarter. Strs Ohio now owns 29,300 shares of the medical instruments supplier’s stock valued at $1,117,000 after purchasing an additional 500 shares in the last quarter. Finally, Great West Life Assurance Co. Can raised its position in Merit Medical Systems by 6.3% during the second quarter. Great West Life Assurance Co. Can now owns 72,856 shares of the medical instruments supplier’s stock valued at $2,775,000 after purchasing an additional 4,310 shares in the last quarter. Institutional investors and hedge funds own 90.89% of the company’s stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at $43.60 on Wednesday. The stock has a market cap of $2,168.59, a price-to-earnings ratio of 34.02, a PEG ratio of 2.93 and a beta of 1.23. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. Merit Medical Systems, Inc. has a 1-year low of $24.23 and a 1-year high of $45.50.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The company had revenue of $179.30 million for the quarter, compared to analysts’ expectations of $181.28 million. During the same quarter in the previous year, the firm posted $0.26 earnings per share. Merit Medical Systems’s revenue for the quarter was up 14.2% on a year-over-year basis. research analysts predict that Merit Medical Systems, Inc. will post 1.27 EPS for the current fiscal year.

In related news, Director Kent W. Stanger sold 670 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $42.06, for a total value of $28,180.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In the last three months, insiders sold 5,518 shares of company stock worth $239,276. 5.00% of the stock is currently owned by insiders.

Several brokerages have recently issued reports on MMSI. BidaskClub downgraded shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a report on Tuesday. ValuEngine downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Wells Fargo & Company reiterated an “outperform” rating and set a $51.00 price target (up from $46.00) on shares of Merit Medical Systems in a report on Thursday, November 30th. Canaccord Genuity reiterated a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a report on Sunday, October 8th. Finally, SunTrust Banks set a $47.00 price target on shares of Merit Medical Systems and gave the stock a “buy” rating in a report on Thursday, November 16th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company’s stock. Merit Medical Systems currently has a consensus rating of “Buy” and a consensus price target of $43.77.

ILLEGAL ACTIVITY WARNING: “Merit Medical Systems, Inc. (MMSI) Shares Bought by Rhumbline Advisers” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.com-unik.info/2017/12/06/merit-medical-systems-inc-mmsi-shares-bought-by-rhumbline-advisers.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

What are top analysts saying about Merit Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merit Medical Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit